0001694244-22-000001.txt : 20220228 0001694244-22-000001.hdr.sgml : 20220228 20220228090348 ACCESSION NUMBER: 0001694244-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 EFFECTIVENESS DATE: 20220228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Osmol Therapeutics, Inc. CENTRAL INDEX KEY: 0001694244 IRS NUMBER: 814728978 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-435142 FILM NUMBER: 22684259 BUSINESS ADDRESS: STREET 1: 33 WHITNEY AVENUE STREET 2: 3RD FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-606-5600 MAIL ADDRESS: STREET 1: 33 WHITNEY AVENUE STREET 2: 3RD FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 D 1 primary_doc.xml X0708 D LIVE 0001694244 Osmol Therapeutics, Inc. 33 WHITNEY AVENUE Suite 2B NEW HAVEN CT CONNECTICUT 06510 617-719-9406 DELAWARE None None Corporation true Robert Berman 33 Whitney Avenue Suite 2B New Haven CT CONNECTICUT 06510 Director Michael Ehrlich 33 Whitney Avenue Suite 2B New Haven CT CONNECTICUT 06510 Director Robert Linke 33 Whitney Avenue Suite 2B New Haven CT CONNECTICUT 06510 Executive Officer Director Vlad Coric 33 Whitney Avenue Suite 2B New Haven CT CONNECTICUT 06510 Director Biotechnology Decline to Disclose 06c false 2022-02-14 false true false 0 7500000 2300000 5200000 false 4 0 0 0 false Osmol Therapeutics, Inc. Robert Berman Dr. Robert Berman President and CEO 2022-02-28